More than six out of ten Connecticut voters favor legalizing marijuana use by adults, according to statewide polling conducted by Quinnipiac University.
Sixty-three percent of respondents said that they favored permitting adults to legally possess personal use quantities of cannabis. Only 34 percent of voters opposed this idea.
Legislation, House Bill 6703, is presently pending in the state, “to allow marijuana use for persons twenty-one years of age and older, and to regulate the sale, possession, use and growth of marijuana.” Connecticut residents can contact their lawmakers in support of this measure here.
State voters, by an overwhelming 82 percent to 15 percent margin, also support eliminating mandatory minimum sentences for offenses involving the possession of small amounts of illegal drugs, and allowing judges to decide sentences on a case by case basis.
The Quinnipiac University poll possesses a margin of error of +/- 2.8 percentage points.
Nine out of ten Connecticut voters support legalizing the use of cannabis for medicinal purposes, and a majority support allowing adults to possess the plant for any purpose, according to the results of a statewide Quinnipiac University poll, released today.
Fifty-two percent of voters support allowing adults “to legally possess small amounts of marijuana for personal use.” Forty-five percent of respondents opposed the idea.
Independents (61 percent), Democrats (52 percent), and men (54 percent) were most likely to endorse legalization, while women (49 percent) and Republicans (38 percent) were least supportive
When asked whether patients ought to be able to access cannabis for medicinal purposes, public support rose to 90 percent. State lawmakers authorized physicians to recommend cannabis therapy in 2012. However, although some 2,000 Connecticut patients are now authorized to use medicinal cannabis, no state-licensed dispensaries are presently operational.
According to the poll, 47 percent of Connecticut voters — including 62 percent of those between the ages of 18 and 29 — acknowledge having tried marijuana.
By a margin of nearly 2 to 1, respondents said that alcohol is “more harmful to society” than cannabis.
Commenting on the poll, NORML Deputy Director Paul Armentano said, “The most remarkable thing about these results is that they are no longer remarkable.”
The Quinnipiac survey possesses a margin of error of +/- 2.4 percentage points.
#1 Colorado and Washington Vote To Legalize Marijuana
Voters in Colorado and Washington made history by approving ballot measures allowing for the personal possession and consumption of cannabis by adults. Washington’s law, which removes criminal penalties for the possession of up to one ounce of cannabis for personal use (as well as the possession of up to 16 ounces of marijuana-infused product in solid form, and 72 ounces of marijuana-infused product in liquid form), took effect on December 6. Colorado’s law, which allows for the legal possession of up to one ounce of marijuana and/or the cultivation of up to six cannabis plants in private by those persons age 21 and over, took effect on December 10. Regulators in both states are now in the process of drafting rules to allow for state-licensed proprietors to commercially produce and sell cannabis.
#2 Most Americans Favor Legalization, Want The Feds To Butt Out
A majority of Americans support legalizing the use of cannabis by adults, according to national polls by Public Policy Polling, Angus Reid, Quinnipiac University, and others. A record high 83 percent of US citizens favor allowing doctors to authorize specified amounts of marijuana for patients suffering from serious illnesses. And nearly two-thirds of Americans oppose federal interference in state laws that allow for legal marijuana use by adults.
#3 Connecticut, Massachusetts Legalize Cannabis Therapy
Connecticut and Massachusetts became the 17th and 18th states to allow for the use of cannabis when recommended by a physician. Connecticut lawmakers in May approved Public Act 12-55, An Act Concerning the Palliative Use of Marijuana. The new law took effect on October 1. On Election Day, 63 percent of Massachusetts voters approved Question 3, eliminating statewide criminal and civil penalties related to the possession and use of up to a 60-day supply of cannabis by qualified patients. The law takes effect on January 1, 2013.
#4 Schedule I Prohibitive Status For Pot “Untenable,” Scientists Say
The classification of cannabis and its organic compounds as Schedule I prohibited substances under federal law is scientifically indefensible, according to a review published online in May in The Open Neurology Journal. Investigators at the University of California at San Diego and the University of California, Davis reviewed the results of several recent clinical trials assessing the safety and efficacy of inhaled or vaporized cannabis. They concluded: “Based on evidence currently available the Schedule I classification is not tenable; it is not accurate that cannabis has no medical value, or that information on safety is lacking.”
#5 Marijuana Arrests Decline, But Still Total Half Of All Illicit Drug Violations
Police made 757,969 arrests in 2011 for marijuana-related offenses, according to the Federal Bureau of Investigation’s annual Uniform Crime Report. The total marked a decline from previous years. Of those charged in 2011 with marijuana law violations, 663,032 (86 percent) were arrested for marijuana offenses involving possession only. According to the report, approximately 43 percent of all drug violations in 2011 were for cannabis possession.
#6 Long-Term Cannabis Exposure Not Associated With Adverse Lung Function
Exposure to moderate levels of cannabis smoke, even over the long-term, is not associated with adverse effects on pulmonary function, according to clinical trial data published in January in the Journal of the American Medical Association. Investigators at the University of California, San Francisco analyzed the association between marijuana exposure and pulmonary function over a 20-year period in a cohort of 5,115 men and women in four US cities. They concluded: “With up to 7 joint-years of lifetime exposure (e.g., 1 joint/d for 7 years or 1 joint/wk for 49 years), we found no evidence that increasing exposure to marijuana adversely affects pulmonary function. … Our findings suggest that occasional use of marijuana … may not be associated with adverse consequences on pulmonary function.”
#7 Cannabis Use Associated With Decreased Prevalence Of Diabetes
Adults with a history of marijuana use have a lower prevalence of type 2 diabetes and possess a lower risk of contracting the disease than do those with no history of cannabis consumption, according to clinical trial data published in the British Medical Journal. Investigators at the University of California, Los Angeles assessed the association between diabetes mellitus (DM) and marijuana use among adults aged 20 to 59 in a nationally representative sample of the US population of 10,896 adults. Investigators concluded, “Our analysis of adults aged 20-59 years … Showed that participants who used marijuana had a lower prevalence of DM and lower odds of DM relative to non-marijuana users.”
#8 Medical Cannabis Dispensaries Not Associated With Neighborhood Crime
The establishment of medical cannabis dispensaries does not adversely impact local crime rates, according to a federally funded study published in the July issue of the Journal of Studies on Alcohol and Drugs. Researchers reported: “There were no observed cross-sectional associations between the density of medical marijuana dispensaries and either violent or property crime rates in this study.”
#9 Rhode Island Becomes The 15th State To Decriminalize Pot Possession Penalties
Governor Lincoln Chafee signed legislation into law in June amending marijuana possession penalties for those age 18 or older from a criminal misdemeanor (punishable by one year in jail and a $500 maximum fine) to a non-arrestable civil offense — punishable by a $150 fine, no jail time, and no criminal record. The decriminalization law takes effect on April 1, 2013.
#10 Cannabis Reduces Symptoms In Patients With Treatment-Resistant MS
Cannabis inhalation mitigates spasticity and pain in patients with treatment-resistant multiple sclerosis (MS), according to clinical trial data published online in May in the Journal of the Canadian Medical Association. Investigators at the University of California, San Diego assessed the use of inhaled cannabis versus placebo in 30 patients with MS who were unresponsive to conventional treatments. “Smoked cannabis was superior to placebo in symptom and pain reduction in patients with treatment-resistant spasticity,” authors concluded.
This morning Connecticut officially became the 17th state since 1996 to allow for the physician-authorized use of cannabis as a therapeutic option for qualified patients.
House Bill 5389 — the Palliative Use of Marijuana Act — which was signed into law on by Democrat Gov. Dan Malloy on June 1, took effect today. Online registration for qualifying patients and their physicians is now available from the Connecticut Department of Consumer Protection here.
Applicable qualifying medical conditions under the law include: cancer, glaucoma, positive status for human immunodeficiency virus or acquired immune deficiency syndrome, Parkinson’s disease, multiple sclerosis, damage to the nervous tissue of the spinal cord with objective neurological indication of intractable spasticity, epilepsy, cachexia, wasting syndrome, Crohn’s disease, and Post-Traumatic Stress Disorder.
The Department of Consumer Protection has until July 1 to submit regulations to the General Assembly regarding the eventual state-licensed distribution of cannabis. In the interim, qualified patients will be allowed to lawfully to possess up to 2.5 ounces of cannabis. However, “until state-approved sources of medical marijuana are established, transactions to obtain the drug will still be illegal,” according to today’s Norwich Bulletin. (Home cultivation is not explicitly addressed under the statute.)
Additional information for Connecticut patients and physicians regarding Public Act 12-55, An Act Concerning the Palliative Use of Marijuana is available online from the state Department of Consumer Protection here.
Democrat Gov. Dan Malloy signed legislation into law on Friday, June 1, allowing for the state-sanctioned production, distribution, and use of cannabis for therapeutic purposes. The new law – Public Act 12-55, An Act Concerning the Palliative Use of Marijuana – will take effect on October 1, 2012.
“For years, we’ve heard from so many patients with chronic diseases who undergo treatments like chemotherapy or radiation and are denied the palliative benefits that medical marijuana would provide,” Governor Malloy said in a prepared statement. (Read it here.) “With careful regulation and safeguards, this law will allow a doctor and a patient to decide what is in that patient’s best interest.”
Under the law, patients with a qualifying “debilitating medical condition” must receive “written certification” from a physician and register with the state’s Department of Consumer Protection (DCP). Qualifying patients and their primary caregivers will be allowed to possess a combined one-month supply of cannabis, the specific amount of which will be determined by a board consisting of eight physicians certified by appropriate medical boards and enforced through DCP regulations. Patients may obtain marijuana from certified pharmacists at licensed dispensaries, who will obtain it from licensed producers. The law allows for the licensing of at least three, but no more than ten, producers statewide.
Said Erik Williams, Executive Director of Connecticut NORML, who assisted in drafting the bill and generated over 36,000 phone calls and e-mails to lawmakers in support of the measure, “I am so happy for all the patients who will have another medicinal option to discuss with their doctor and for all of those currently suffering with debilitating conditions who will no longer suffer the indignity of being sick and a criminal.”
Connecticut is the 17th state since 1996 to allow for the limited legalization of medicinal cannabis. It is the fourth New England state to do so, joining Maine, Rhode Island, and Vermont — each of which allow for qualified patients to possess and cultivate limited quantities of the plant.
Late last month, Rhode Island Gov. Lincoln Chafee signed into law similar legislation allowing for the state-licensed production and limited distribution of medicinal cannabis. Vermont lawmakers in 2011 approved a similar measure; however, to date the state has yet to license any statewide dispensaries. Presently, a total of eight state-licensed medical marijuana dispensaries are operating in Maine.
Similar state-licensed dispensaries operate in Colorado and New Mexico. Additional licensing legislation awaits implementation in Arizona, Delaware, New Jersey, and Washington, DC.